384 related articles for article (PubMed ID: 24814360)
1. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
[TBL] [Abstract][Full Text] [Related]
2. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors.
Roubidoux MA; Bailey JE; Wray LA; Helvie MA
Radiology; 2004 Jan; 230(1):42-8. PubMed ID: 14695385
[TBL] [Abstract][Full Text] [Related]
3. Tubular carcinoma of the breast: mode of presentation, mammographic appearance, and frequency of nodal metastases.
Elson BC; Helvie MA; Frank TS; Wilson TE; Adler DD
AJR Am J Roentgenol; 1993 Dec; 161(6):1173-6. PubMed ID: 8249721
[TBL] [Abstract][Full Text] [Related]
4. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999.
Vacek PM; Geller BM; Weaver DL; Foster RS
Cancer; 2002 Apr; 94(8):2160-8. PubMed ID: 12001112
[TBL] [Abstract][Full Text] [Related]
5. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer.
Jiang L; Ma T; Moran MS; Kong X; Li X; Haffty BG; Yang Q
Anticancer Res; 2011 Jun; 31(6):2327-34. PubMed ID: 21737659
[TBL] [Abstract][Full Text] [Related]
6. Do pathological parameters differ with regard to breast density and mode of detection in breast cancer? The Malmö Diet and Cancer Study.
Sartor H; Borgquist S; Hartman L; Zackrisson S
Breast; 2015 Feb; 24(1):12-7. PubMed ID: 25433452
[TBL] [Abstract][Full Text] [Related]
7. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.
Tabar L; Tony Chen HH; Amy Yen MF; Tot T; Tung TH; Chen LS; Chiu YH; Duffy SW; Smith RA
Cancer; 2004 Oct; 101(8):1745-59. PubMed ID: 15386334
[TBL] [Abstract][Full Text] [Related]
8. Association between mammographic breast density and breast cancer tumor characteristics.
Aiello EJ; Buist DS; White E; Porter PL
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):662-8. PubMed ID: 15767347
[TBL] [Abstract][Full Text] [Related]
9. Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival.
Lång K; Sturesdotter L; Bengtsson Y; Larsson AM; Sartor H
Breast; 2024 Jun; 75():103736. PubMed ID: 38663074
[TBL] [Abstract][Full Text] [Related]
10. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
11. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
13. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
[TBL] [Abstract][Full Text] [Related]
14. Axillary lymph nodes: mammographic, pathologic, and clinical correlation.
Walsh R; Kornguth PJ; Soo MS; Bentley R; DeLong DM
AJR Am J Roentgenol; 1997 Jan; 168(1):33-8. PubMed ID: 8976915
[TBL] [Abstract][Full Text] [Related]
15. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
16. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.
Yaghjyan L; Colditz GA; Collins LC; Schnitt SJ; Rosner B; Vachon C; Tamimi RM
J Natl Cancer Inst; 2011 Aug; 103(15):1179-89. PubMed ID: 21795664
[TBL] [Abstract][Full Text] [Related]
17. [The effect of mammographic screening on tumor size, axillary node status and the degree of histologic anaplasia].
Garami Z; Benkó K; Kósa C; Fülöp B; Lukács G
Magy Seb; 2006 Oct; 59(5):383-7. PubMed ID: 17201347
[TBL] [Abstract][Full Text] [Related]
18. Spiculated axillary adenopathy.
Dershaw DD; Selland DG; Tan LK; Morris EA; Abramson AF; Liberman L
Radiology; 1996 Nov; 201(2):439-42. PubMed ID: 8888237
[TBL] [Abstract][Full Text] [Related]
19. Varying levels of family history of breast cancer in relation to mammographic breast density (United States).
Crest AB; Aiello EJ; Anderson ML; Buist DS
Cancer Causes Control; 2006 Aug; 17(6):843-50. PubMed ID: 16783612
[TBL] [Abstract][Full Text] [Related]
20. Pathological axillary lymph nodes detected at mammographic screening.
Lim ET; O'Doherty A; Hill AD; Quinn CM
Clin Radiol; 2004 Jan; 59(1):86-91. PubMed ID: 14697380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
